Delivery Order SPE2DB22D3004-SPE2DB26FQ75A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Addyi 100 mg tablets in quantities of 30 units, valued at $4,767.92. This competitively awarded, non-set-aside contract was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and operates under firm fixed pricing terms. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.19 to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of ADDYI (flibanserrin) 100 mg tablets in quantities of 30 units, with a contract ceiling value of $2,030.63. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,184.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserina) 100 mg tablets in quantities of 30 units. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a $4,319.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. The award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,675.92 for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded without set-aside designation under a firm fixed price structure. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,174.04 to AmerisourceBergen Drug Corp for supply of ADDYI (flibanserins) 100 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 9, 2025, and was awarded on May 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserene) 100 mg tablets in quantities of 30 units, with a ceiling value of $41,739.01. This firm fixed price delivery order, awarded September 4, 2025, with ultimate completion by September 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $5,959.27 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on September 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ75ADelivery Order
The Defense Logistics Agency awarded a $3,326.74 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Addyi (flibanserin) 100 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling varied pharmaceutical needs across multiple therapeutic domains through firm fixed-price delivery orders with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/24/25 |